"Despite the help offered by this classification system, the BI-RADS 3 category includes probably benign lesions whose management has been widely debated in the literature," wrote Chiara Adriana Pistolese, from the department of diagnostic imaging at Tor Vergata University Rome in Italy, and colleagues.

A new study found that rates of supplemental screening among black women with dense breasts increased after the passage of statewide mandatory breast density notification laws, according to research published Oct. 18 in the Journal of the American College of Radiology.

Continuing its efforts to empower clinicians and patients in their fight against breast cancer, GE Healthcare today launched the Invenia Automated Breast Ultrasound (ABUS) 2.0 in the United States.

Breast ultrasound should be used as the primary initial imaging modality when evaluating focal breast symptoms in women 30 to 39 years old, according to research published Oct. 9 in the American Journal of Roentgenology. Although mammography can detect symptomatic breast cancer, the researchers found its cancer detection rate (CDR) to be lower than that of ultrasound.

On Wednesday, Oct. 10, the Society of Breast Imaging (SBI) and Oxford University Press (OUP) announced a partnership to publish the Journal of Breast Imaging (JBI)—the first peer-reviewed journal dedicated to breast imaging.

Researchers have found that malignant and nonmalignant architectural distortion (AD) in breast imaging exams are better detected by (three-dimensional) 3D mammography than (two-dimensional) 2D, according to a study published online Sept. 21 in the American Journal of Roentgenology.

Diffusion-weighted imaging (DWI) could help differentiate between benign and malignant tumors and predict tumor recurrence in breast cancer patients, according to research published Oct. 4 in Academic Radiology. The authors noted that DWI may also serve as a beneficial supplement to contrast-enhanced breast MRI.

A 18F-FDG PET/CT scan can reveal previously undetected breast cancer in more than one-third of newly diagnosed male patients, according to research published Sept. 20 in the Journal of Nuclear Medicine.